NewAmsterdam Pharma Co NV (NewAmsterdam Pharma Co NV) Gross-Profit-to-Asset % : 1.72% (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is NewAmsterdam Pharma Co NV Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. NewAmsterdam Pharma Co NV's annualized Gross Profit for the quarter that ended in Dec. 2023 was $7.40 Mil. NewAmsterdam Pharma Co NV's average Total Assets over the quarter that ended in Dec. 2023 was $429.53 Mil. Therefore, NewAmsterdam Pharma Co NV's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 1.72%.

NewAmsterdam Pharma Co NV Gross-Profit-to-Asset % Historical Data

The historical data trend for NewAmsterdam Pharma Co NV's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NewAmsterdam Pharma Co NV Gross-Profit-to-Asset % Chart

NewAmsterdam Pharma Co NV Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Gross-Profit-to-Asset %

37.60

3.41

NewAmsterdam Pharma Co NV Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Gross-Profit-to-Asset %	Get a 7-Day Free Trial			-	132.32	2.85	4.20	1.72

Competitive Comparison of NewAmsterdam Pharma Co NV's Gross-Profit-to-Asset %

For the Biotechnology subindustry, NewAmsterdam Pharma Co NV's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NewAmsterdam Pharma Co NV's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NewAmsterdam Pharma Co NV's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where NewAmsterdam Pharma Co NV's Gross-Profit-to-Asset % falls into.

NewAmsterdam Pharma Co NV Gross-Profit-to-Asset % Calculation

NewAmsterdam Pharma Co NV's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2023 )	/	( (Total Assets (A: Dec. 2022 )	+	Total Assets (A: Dec. 2023 ))	/ count )
	=	14.09	/	( (478.497	+	347.097)	/ 2 )
	=	14.09	/	412.797
	=	3.41 %

NewAmsterdam Pharma Co NV's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	7.398	/	( (511.963	+	347.097)	/ 2 )
	=	7.398	/	429.53
	=	1.72 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

NewAmsterdam Pharma Co NV Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of NewAmsterdam Pharma Co NV's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

NewAmsterdam Pharma Co NV (NewAmsterdam Pharma Co NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NewAmsterdam Pharma Co NV (NAS:NAMS) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

KH6:Germany

Address

Gooimeer 2-35, Naarden, NH, NLD, 1411 DC

Website

https://www.newamsterdampharma.com

NewAmsterdam Pharma Co NV is a clinical-stage company focused on the research and development of transformative therapies for metabolic diseases and Alzheimer's disease.